CD34+ cell selection is required to assess HOXA9 expression levels in patients with myelodysplastic syndrome

Stefan Heinrichs, Jason N. Berman, Taylor M. Ortiz, Steven M. Kornblau, Donna S. Neuberg, Elihu H. Estey, A. Thomas Look

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)

Fingerprint

Dive into the research topics of 'CD34+ cell selection is required to assess HOXA9 expression levels in patients with myelodysplastic syndrome'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology